These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

445 related items for PubMed ID: 26645117

  • 1. Transcutaneous posterior tibial nerve stimulation versus extended release oxybutynin in overactive bladder patients. A prospective randomized trial.
    Manríquez V, Guzmán R, Naser M, Aguilera A, Narvaez S, Castro A, Swift S, Digesu GA.
    Eur J Obstet Gynecol Reprod Biol; 2016 Jan; 196():6-10. PubMed ID: 26645117
    [Abstract] [Full Text] [Related]

  • 2. Prospective and randomized comparison of electrical stimulation of the posterior tibial nerve versus oxybutynin versus their combination for treatment of women with overactive bladder syndrome.
    Souto SC, Reis LO, Palma T, Palma P, Denardi F.
    World J Urol; 2014 Feb; 32(1):179-84. PubMed ID: 23749315
    [Abstract] [Full Text] [Related]

  • 3. A single-blind, randomized controlled trial to evaluate the effectiveness of transcutaneous tibial nerve stimulation (TTNS) in Overactive Bladder symptoms in women responders to percutaneous tibial nerve stimulation (PTNS).
    Martin-Garcia M, Crampton J.
    Physiotherapy; 2019 Dec; 105(4):469-475. PubMed ID: 30862384
    [Abstract] [Full Text] [Related]

  • 4. Percutaneous tibial nerve stimulation versus tolterodine for overactive bladder in women: a randomised controlled trial.
    Preyer O, Umek W, Laml T, Bjelic-Radisic V, Gabriel B, Mittlboeck M, Hanzal E.
    Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():51-6. PubMed ID: 26073262
    [Abstract] [Full Text] [Related]

  • 5. Patient-reported outcomes in the setting of a randomized control trial on the efficacy of transcutaneous stimulation of the posterior tibial nerve compared to percutaneous stimulation in idiopathic overactive bladder syndrome.
    Ramírez-García I, Kauffmann S, Blanco-Ratto L, Carralero-Martínez A, Sánchez E.
    Neurourol Urodyn; 2021 Jan; 40(1):295-302. PubMed ID: 33118624
    [Abstract] [Full Text] [Related]

  • 6. Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the overactive bladder innovative therapy trial.
    Peters KM, Macdiarmid SA, Wooldridge LS, Leong FC, Shobeiri SA, Rovner ES, Siegel SW, Tate SB, Jarnagin BK, Rosenblatt PL, Feagins BA.
    J Urol; 2009 Sep; 182(3):1055-61. PubMed ID: 19616802
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of transcutaneous stimulation of the posterior tibial nerve compared to percutaneous stimulation in idiopathic overactive bladder syndrome: Randomized control trial.
    Ramírez-García I, Blanco-Ratto L, Kauffmann S, Carralero-Martínez A, Sánchez E.
    Neurourol Urodyn; 2019 Jan; 38(1):261-268. PubMed ID: 30311692
    [Abstract] [Full Text] [Related]

  • 8. Superiority of fesoterodine 8 mg vs 4 mg in reducing urgency urinary incontinence episodes in patients with overactive bladder: results of the randomised, double-blind, placebo-controlled EIGHT trial.
    Chapple C, Schneider T, Haab F, Sun F, Whelan L, Scholfield D, Dragon E, Mangan E.
    BJU Int; 2014 Sep; 114(3):418-26. PubMed ID: 24552358
    [Abstract] [Full Text] [Related]

  • 9. Transcutaneous posterior tibial nerve stimulation in pediatric overactive bladder: A preliminary report.
    Patidar N, Mittal V, Kumar M, Sureka SK, Arora S, Ansari MS.
    J Pediatr Urol; 2015 Dec; 11(6):351.e1-6. PubMed ID: 26279104
    [Abstract] [Full Text] [Related]

  • 10. Sustained therapeutic effects of percutaneous tibial nerve stimulation: 24-month results of the STEP study.
    Peters KM, Carrico DJ, MacDiarmid SA, Wooldridge LS, Khan AU, McCoy CE, Franco N, Bennett JB.
    Neurourol Urodyn; 2013 Jan; 32(1):24-9. PubMed ID: 22674493
    [Abstract] [Full Text] [Related]

  • 11. Posterior tibial nerve stimulation vs parasacral transcutaneous neuromodulation for overactive bladder in children.
    Barroso U, Viterbo W, Bittencourt J, Farias T, Lordêlo P.
    J Urol; 2013 Aug; 190(2):673-7. PubMed ID: 23422257
    [Abstract] [Full Text] [Related]

  • 12. A novel leadless, miniature implantable Tibial Nerve Neuromodulation System for the management of overactive bladder complaints.
    Heesakkers JPFA, Digesu GA, van Breda J, Van Kerrebroeck P, Elneil S.
    Neurourol Urodyn; 2018 Mar; 37(3):1060-1067. PubMed ID: 28892221
    [Abstract] [Full Text] [Related]

  • 13. Solifenacin succinate versus percutaneous tibial nerve stimulation in women with overactive bladder syndrome: results of a randomized controlled crossover study.
    Vecchioli-Scaldazza C, Morosetti C, Berouz A, Giannubilo W, Ferrara V.
    Gynecol Obstet Invest; 2013 Mar; 75(4):230-4. PubMed ID: 23548260
    [Abstract] [Full Text] [Related]

  • 14. Comparison of electric stimulation and oxybutynin chloride in management of overactive bladder with special reference to urinary urgency: a randomized placebo-controlled trial.
    Wang AC, Chih SY, Chen MC.
    Urology; 2006 Nov; 68(5):999-1004. PubMed ID: 17113893
    [Abstract] [Full Text] [Related]

  • 15. Percutaneous tibial nerve stimulation versus sham efficacy in the treatment of refractory overactive bladder: outcomes following a shortened 6-week protocol, a prospective randomized controlled trial.
    Lashin AM, Eltabey NA, Wadie BS.
    Int Urol Nephrol; 2021 Dec; 53(12):2459-2467. PubMed ID: 34601705
    [Abstract] [Full Text] [Related]

  • 16. Percutaneous Tibial Nerve Stimulation Improves Female Sexual Function in Women With Overactive Bladder Syndrome.
    Musco S, Serati M, Lombardi G, Lumi E, Parisi AI, Del Popolo G, Finazzi Agrò E.
    J Sex Med; 2016 Feb; 13(2):238-42. PubMed ID: 26803455
    [Abstract] [Full Text] [Related]

  • 17. Effectiveness and durability of solifenacin versus percutaneous tibial nerve stimulation versus their combination for the treatment of women with overactive bladder syndrome: a randomized controlled study with a follow-up of ten months.
    Vecchioli-Scaldazza C, Morosetti C.
    Int Braz J Urol; 2018 Feb; 44(1):102-108. PubMed ID: 29064651
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of fesoterodine compared with extended-release tolterodine in men and women with overactive bladder.
    Ginsberg D, Schneider T, Kelleher C, Van Kerrebroeck P, Swift S, Creanga D, Martire DL.
    BJU Int; 2013 Aug; 112(3):373-85. PubMed ID: 23826844
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and tolerability of fesoterodine versus tolterodine in older and younger subjects with overactive bladder: a post hoc, pooled analysis from two placebo-controlled trials.
    DuBeau CE, Morrow JD, Kraus SR, Creanga D, Bavendam T.
    Neurourol Urodyn; 2012 Nov; 31(8):1258-65. PubMed ID: 22907761
    [Abstract] [Full Text] [Related]

  • 20. Percutaneous tibial nerve stimulation for the long-term treatment of overactive bladder: 3-year results of the STEP study.
    Peters KM, Carrico DJ, Wooldridge LS, Miller CJ, MacDiarmid SA.
    J Urol; 2013 Jun; 189(6):2194-201. PubMed ID: 23219541
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.